Long-Term Outcomes Among Patients Discharged From the Hospital With Moderate Anemia: A Retrospective Cohort Study
- PMID: 30557414
- PMCID: PMC6639156
- DOI: 10.7326/M17-3253
Long-Term Outcomes Among Patients Discharged From the Hospital With Moderate Anemia: A Retrospective Cohort Study
Abstract
Background: Randomized clinical trial findings support decreased red blood cell (RBC) transfusion and short-term tolerance of in-hospital anemia. However, long-term outcomes related to changes in transfusion practice have not been described.
Objective: To describe the prevalence of anemia at and after hospital discharge and associated morbidity and mortality events.
Design: Retrospective cohort study.
Setting: Integrated health care delivery system with 21 hospitals serving 4 million members.
Participants: 445 371 surviving adults who had 801 261 hospitalizations between January 2010 and December 2014.
Measurements: Hemoglobin levels and RBC transfusion, rehospitalization, and mortality events within 6 months of hospital discharge. Generalized estimating equations were used to examine trends over time, accounting for correlated observations and patient-level covariates.
Results: From 2010 to 2014, the prevalence of moderate anemia (hemoglobin levels between 7 and 10 g/dL) at hospital discharge increased from 20% to 25% (P < 0.001) and RBC transfusion declined by 28% (39.8 to 28.5 RBC units per 1000 patients; P < 0.001). The proportion of patients whose moderate anemia had resolved within 6 months of hospital discharge decreased from 42% to 34% (P < 0.001), and RBC transfusion and rehospitalization within 6 months of hospital discharge decreased from 19% to 17% and 37% to 33%, respectively (P < 0.001 for both). During this period, the adjusted 6-month mortality rate decreased from 16.1% to 15.6% (P = 0.004) in patients with moderate anemia, in parallel with that of all others.
Limitation: Possible unmeasured confounding.
Conclusion: Anemia after hospitalization increased in parallel with decreased RBC transfusion. This increase was not accompanied by a rise in subsequent RBC use, rehospitalization, or mortality within 6 months of hospital discharge. Longitudinal analyses support the safety of practice recommendations to limit RBC transfusion and tolerate anemia during and after hospitalization.
Primary funding source: National Heart, Lung, and Blood Institute.
Figures
Comment in
-
From Tolerating Anemia to Treating Anemia.Ann Intern Med. 2019 Jan 15;170(2):125-126. doi: 10.7326/M18-3145. Epub 2018 Dec 18. Ann Intern Med. 2019. PMID: 30557445 No abstract available.
References
-
- Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Ut-tley G, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA. 2007;297:2481–8. [PMID: ] - PubMed
-
- Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348:1055–60. [PMID: ] - PubMed
-
- Goodnough LT, Bach RG. Anemia, transfusion, and mortality [Editorial]. N Engl J Med. 2001;345:1272–4. [PMID: ] - PubMed
-
- Goodnough LT, Nissenson AR. Anemia and its clinical consequences in patients with chronic diseases. Am J Med. 2004;116 Suppl 7A:1S–2S [PMID: ] - PubMed
-
- Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, Mc-Camish MA, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004;110:149–54. [PMID: ] - PubMed